Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Baselga

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Science (New York, N.Y.)|May 27, 2006
Targeting tyrosine kinases in cancer: the second waveJose Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Is there a role for the irreversible epidermal growth factor receptor inhibitor EKB-569 in the treatment of cancer? A mutation-driven questionJose Baselga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Skin as a surrogate tissue for pharmacodynamic end points: is it deep enough?Jose Baselga
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2013
Bringing precision medicine to the clinic: from genomic profiling to the power of clinical observationJose Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors: small molecules, big hopesJose Baselga
Cancer Cell|September 3, 2002
A new anti-ErbB2 strategy in the treatment of cancer: prevention of ligand-dependent ErbB2 receptor heterodimerizationJose Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact?Jose Baselga
The Oncologist|April 5, 2007
Targeting the microtubules in breast cancer beyond taxanes: the epothilonesJavier Cortes, Jose Baselga
Hematology/Oncology Clinics of North America|January 7, 2003
Epithelial growth factor receptor interacting agentsJose Baselga, Joan Albanell
Cancer Cell|June 28, 2002
Focus on breast cancerJose Baselga, Larry Norton
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Science (New York, N.Y.)|May 27, 2006
Targeting tyrosine kinases in cancer: the second waveJose Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Is there a role for the irreversible epidermal growth factor receptor inhibitor EKB-569 in the treatment of cancer? A mutation-driven questionJose Baselga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Skin as a surrogate tissue for pharmacodynamic end points: is it deep enough?Jose Baselga
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2013
Bringing precision medicine to the clinic: from genomic profiling to the power of clinical observationJose Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors: small molecules, big hopesJose Baselga
Cancer Cell|September 3, 2002
A new anti-ErbB2 strategy in the treatment of cancer: prevention of ligand-dependent ErbB2 receptor heterodimerizationJose Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact?Jose Baselga
The Oncologist|April 5, 2007
Targeting the microtubules in breast cancer beyond taxanes: the epothilonesJavier Cortes, Jose Baselga
Hematology/Oncology Clinics of North America|January 7, 2003
Epithelial growth factor receptor interacting agentsJose Baselga, Joan Albanell
Cancer Cell|June 28, 2002
Focus on breast cancerJose Baselga, Larry Norton
Pageof 13